<?xml version="1.0" ?> 
 <rss version="2.0">
 <channel>
  <title>Cancer Monthly</title> 
  <link>http://www.cancermonthly.com/</link> 
  <description>Latest Cancer Research</description> 
  <language>en-us</language> 
  <copyright>Copyright 2009 Cancer Monthly. All Rights Reserved.</copyright> 
 <item>
  <title><strong>Latest Cancer Research</strong></title> 
  <link>http://www.cancermonthly.com/cancerwire.asp</link> 
  <description>In this edition of CancerWire we focus on four new studies: <p>* The traditional Chinese herb Scutellaria (called skullcaps in the West) contains a combination of plant chemicals that together can significantly slow the growth of several different cancers, according to a study published in the January 2009 issue of Planta Medica. </p><p>* Adding a mushroom extract to interferon therapy for prostate cancer significantly improves the treatment's effectiveness, and may help reduce both its cost and side effects, according to a study published in the Journal of Hematology and Oncology. </p><p>* An herb many Americans take to get an energy boost might also help doctors treat one of the most common-and deadly-cancers. Researchers have discovered that ginseng, particularly when heated, may be very effective against colorectal cancer, according to a study in The American Journal of Chinese Medicine. </p><p>* Why are the overwhelming number of studies on natural products and cancer performed in cells and animals and not patients? In a recent study that appeared in the journal Complementary Therapies in Medicine, the authors conclude that rigorous trials are necessary to explore the effectiveness of Chinese herbal medicines. In a special Editor's Note the reason why rigorous trials have not been performed is suggested. </p></description> 
  </item>
</channel>
</rss>